Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 16/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6990787 | 0.98 | PTGS2 (0.56) | PTGS2PTGS1CA12CA2CA9 | |
| SCHEMBL6990070 | 0.89 | PTGS2 (0.71) | PTGS2PTGS1 | |
| SCHEMBL6990691 | 0.88 | PTGS2 (0.54) | PTGS2PTGS1 | |
| SCHEMBL6987745 | 0.87 | PTGS2 (0.53) | PTGS2PTGS1CA2CA1 | |
| SCHEMBL6992321 | 0.86 | PTGS2 (0.71) | PTGS2PTGS1 | |
| SCHEMBL6990955 | 0.86 | PTGS2 (0.54) | PTGS2PTGS1 | |
| SCHEMBL6989032 | 0.86 | PTGS2 (0.54) | PTGS2PTGS1CA12CA2CA9 | |
| SCHEMBL6994862 | 0.85 | PTGS2 (0.53) | PTGS2PTGS1CA2CA1 | |
| SCHEMBL6995595 | 0.85 | PTGS2 (0.53) | PTGS2PTGS1 | |
| SCHEMBL6994660 | 0.84 | PTGS2 (0.74) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0799218-B1 | DIARYL-2-(5H)-FURANONES AS COX-2 INHIBITORS | MERCK FROSST CANADA INC (CA) | 2003-02-19 | — | — | EP | claimed |
| US-6222048-B1 | AS ANTIINFLAMMATORY, ANTIPYRETIC AND ANALGESIC AGENTS; INHIBITS HORMONE INDUCED UTERINE CONTRACTION; ANTICANCER PROPERTIES; SIDE EFFECT REDUCTION | MERCK FROSST CANADA & CO. (CA) | 2001-04-24 | — | — | US | claimed |
| EP-0799218-B1 | DIARYL-2-(5H)-FURANONES AS COX-2 INHIBITORS | MERCK FROSST CANADA INC (CA) | 2003-02-19 | — | — | EP | disclosed |
| US-6222048-B1 | AS ANTIINFLAMMATORY, ANTIPYRETIC AND ANALGESIC AGENTS; INHIBITS HORMONE INDUCED UTERINE CONTRACTION; ANTICANCER PROPERTIES; SIDE EFFECT REDUCTION | MERCK FROSST CANADA & CO. (CA) | 2001-04-24 | — | — | US | disclosed |